MGARASVLSGGELDRWEKIR
|
Gag(1-20) | human epitope |
MGARASVLSGGKLDAWEKIR
|
Gag(1-20) | human epitope |
MGARASVLSGGKLDeWEKIR
|
Gag(1-20) | subtype-specific susceptible form |
MGARASVLSGGKLDAWEsIR
|
Gag(1-20) | subtype-specific susceptible form |
MGARASVLSGGKLDA-----
|
Gag(1-20) | non-susceptible form |
MGARASVLSGGELDRWEKIR
|
Gag(1-20) | human epitope |
ASVLSGGELDRWEK
|
Gag(5-18) | human epitope |
ASVLSGGKLDAWEKI
|
Gag(5-19) | human epitope |
ASVLSGGELDRWEKI
|
Gag(5-19) | human epitope |
ASVLSGGkLDaWEKI
|
Gag(5-19) | subtype-specific non-susceptible form |
ASiLrGGkLDkWEKI
|
Gag(5-19) | subtype-specific non-susceptible form |
ASVLSGGkLDkWEKI
|
Gag(5-19) | subtype-specific non-susceptible form |
ASVLSGGELDkWEKI
|
Gag(5-19) | subtype-specific non-susceptible form |
SVLSGGELDKWEK
|
Gag(6-18) | A*11:01 human epitope |
SVLSGGELDRWEKI
|
Gag(6-19) | human epitope |
LSGGELDRWEK
|
Gag(8-18) | macaque epitope |
LSGGkLDaWEK
|
Gag(8-18) | subtype-specific non-susceptible form |
SGGELDKWEK
|
Gag(9-18) | A*11:01 human epitope |
SGGELDRWEKIRLRP
|
Gag(9-23) | B44, B60 human epitope |
SGGKLDAWEKIRLRP
|
Gag(9-23) | human epitope |
SGGKLDAWEKIRLRP
|
Gag(9-23) | human epitope |
SGGELDRWEKIRLRP
|
Gag(9-23) | human epitope |
SGGKLDAWEKIRLRPGGK
|
Gag(9-26) | human epitope |
GGKLDKWEKIRLRPG
|
Gag(10-24) | human epitope |
GGeLDrWEKIRLRPG
|
Gag(10-24) | susceptible form |
GGKLDtWEKIRLRPG
|
Gag(10-24) | susceptible form |
GGKLDTWEKIRLRPG
|
Gag(10-24) | human epitope |
GGeLDrWEKIRLRPG
|
Gag(10-24) | susceptible form |
GGKLDkWEKIRLRPG
|
Gag(10-24) | susceptible form |
GGELDRWEKIRLRPG
|
Gag(10-24) | human epitope |
GGkLDtWEKIRLRPG
|
Gag(10-24) | susceptible form |
GGkLDkWEKIRLRPG
|
Gag(10-24) | susceptible form |
GELDRWEKI
|
Gag(11-19) | B*40 human epitope |
GELDRWkKI
|
Gag(11-19) | diminished response; literature escape |
GELDRWEKI
|
Gag(11-19) | B*40 human epitope |
GELDRWEKI
|
Gag(11-19) | B*40 human epitope |
GELDRWEKI
|
Gag(11-19) | B40 human epitope |
GELDRWEKI
|
Gag(11-19) | B*40:02 human epitope |
GELDRWEKI
|
Gag(11-19) | B*40:02 human epitope |
GELDRWEKI
|
Gag(11-19) | B*49:01 human epitope |
GELDRWEKI
|
Gag(11-19) | human epitope |
GQLDRWEKI
|
Gag(11-19) | human epitope |
GeLDRWEKI
|
Gag(11-19) | observed variant |
GELDRWEKI
|
Gag(11-19) | human epitope |
GKLDSWEKIRLR
|
Gag(11-22) | human epitope |
GKLDaWEKIRLR
|
Gag(11-22) | subtype-specific susceptible form |
GKLDAWEKIRLR
|
Gag(11-22) | human epitope |
GELDRWEKIRLRPGGKKKYK
|
Gag(11-30) | B62 human epitope |
GELDRWEKIRLRPGGKKKYK
|
Gag(11-30) | human epitope |
GKLDAWEKIRLRPGGKKKYRL
|
Gag(11-31) | human epitope |
-----WEKIRLRPGG------
|
Gag(11-31) | non-susceptible form; susceptible form |
GKLDAWEKIyLRPGGKKKYRL
|
Gag(11-31) | non-susceptible form; susceptible form |
GKLDkWEKIRLRPGGKKKYRL
|
Gag(11-31) | non-susceptible form; susceptible form |
---DrWEKIRLRPGGKKKYRL
|
Gag(11-31) | non-susceptible form; susceptible form |
GKLDeWEKIRLRPGGKKKYRL
|
Gag(11-31) | non-susceptible form; susceptible form; subtype-specific susceptible form |
GKLDeWEKIRLRPGGKKKYRL
|
Gag(11-31) | non-susceptible form; susceptible form; subtype-specific susceptible form |
KLDKWEKIR
|
Gag(12-20) | A*74:01 human epitope |
ELDRWEKIRL
|
Gag(12-21) | B63 human epitope |
ELDRWEKIRL
|
Gag(12-21) | human epitope |
KLDAWEKIRLR
|
Gag(12-22) | human epitope |
LDRWEKIRLRPGGKK
|
Gag(13-27) | A3, B60 human epitope |
LDAWEKIRLRPGGKK
|
Gag(13-27) | human epitope |
LDRWEKIRLRPGGKK
|
Gag(13-27) | human epitope |
DRWEKIRLRPG
|
Gag(14-24) | B*40 human epitope |
DRWEKIRLRPG
|
Gag(14-24) | B*40 human epitope |
DAWEKIRLRPG
|
Gag(14-24) | human epitope |
RWEKIRLRP
|
Gag(15-23) | A*02:05 human epitope |
WEKIRLRPGGKKKYK
|
Gag(16-30) | human epitope |
WEKIRLRPGGKKKYK
|
Gag(16-30) | human epitope |
EKIRLRPGGKK
|
Gag(17-27) | human epitope |
EKIRLRPGGrK
|
Gag(17-27) | observed variant; susceptible form |
EKIRLReGGrK
|
Gag(17-27) | observed variant |
vKIRLRPGGKK
|
Gag(17-27) | observed variant |
EKIRLRPaGKK
|
Gag(17-27) | observed variant |
EKIRLRPGGsK
|
Gag(17-27) | observed variant |
EKIRLRPGGKr
|
Gag(17-27) | observed variant |
EKIRLRPGGKKKYKL
|
Gag(17-31) | B27, B7 human epitope |
EKIRLRPGGKKKYRL
|
Gag(17-31) | human epitope |
EKIRLRPGGKKKYRL
|
Gag(17-31) | human epitope |
EKIRLRPGGKKKYRL
|
Gag(17-31) | human epitope |
EKIRLRPGGKKKYKL
|
Gag(17-31) | human epitope |
EKIRLRPGGKKKYqL
|
Gag(17-31) | non-susceptible form; susceptible form |
EKIRLRPGGKKHYML
|
Gag(17-31) | human epitope |
EKIRLRPGGKKKYRL
|
Gag(17-31) | human epitope |
EKIRLRPGGKKKYKL
|
Gag(17-31) | human epitope |
EKIRLRPGGKKKYRL
|
Gag(17-31) | human epitope |
EKIRLRPGGKKHYMLKHL
|
Gag(17-34) | C*17 human epitope |
EKIRLRPGGKKKYKLKHI
|
Gag(17-34) | human epitope |
EKIRLRPGGKKKYRLKHL
|
Gag(17-34) | human epitope |
EKIRLRPGGKKKYKLKHI
|
Gag(17-34) | human epitope |
EKIRLRGGKKKYRMKHL
|
Gag(17-34) | human epitope |
EKIRLRPGGKKKYKLKHI
|
Gag(17-34) | human epitope |
EKIRLRPGGKKKYKLKHI
|
Gag(17-34) | human epitope |
EKIRLRPGGKKHYMLKHL
|
Gag(17-34) | human epitope |
EKIRLRPGGKKKYRLKHL
|
Gag(17-34) | human epitope |
EKIRLRPGGKKhYmLKHL
|
Gag(17-34) | subtype-specific susceptible form |
KIRLRPGGK
|
Gag(18-26) | A*03 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*03 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*03 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*03 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*03 human epitope |
KIRLRPGGn
|
Gag(18-26) | susceptible form |
KIRLRPeGK
|
Gag(18-26) | susceptible form |
KIkLRPGGK
|
Gag(18-26) | susceptible form |
KIqLRPGGK
|
Gag(18-26) | susceptible form |
KIkLRPGGr
|
Gag(18-26) | susceptible form |
KIRLRPGGK
|
Gag(18-26) | A*03 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*03 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*03 human epitope |
KIRLRPGGr
|
Gag(18-26) | literature escape; observed variant |
KIRLRPGGK
|
Gag(18-26) | A*03 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*03:01 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*03:01 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*03:01 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*03:01 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*03:01 human epitope |
KIRLRPGGr
|
Gag(18-26) | diminished HLA binding or increased off-rate |
KIRLRPGGK
|
Gag(18-26) | A*03:01 human epitope |
rIRLRPGGK
|
Gag(18-26) | diminished response; escape documented in this paper; non-susceptible form |
KIRLRPGGK
|
Gag(18-26) | A*03:01 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*03:01, A3, B27 human epitope |
KIRLRPGGK
|
Gag(18-26) | A11 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGr
|
Gag(18-26) | inferred escape |
KIRLRPGGK{Kr}
|
Gag(18-26) | observed variant |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGq
|
Gag(18-26) | escape documented in this paper; processing |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGr
|
Gag(18-26) | escape documented in this paper |
rIRLRPGGr
|
Gag(18-26) | escape documented in this paper |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A3 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*30 human epitope |
KIRLRPGGK
|
Gag(18-26) | A*69 human epitope |
KIRLRPGGK
|
Gag(18-26) | B*27 human epitope |
KIRLRPGGK
|
Gag(18-26) | B7 human epitope |
KIRLRPGGK{*t}
|
Gag(18-26) | escape documented in this paper; processing |
KIRLRPGGK
|
Gag(18-26) | B*82 human epitope |
KIRLRPGGK
|
Gag(18-26) | human epitope |
KIRLRPGGK
|
Gag(18-26) | human epitope |
KIRLRPGGK
|
Gag(18-26) | human epitope |
KIRLRPGGK
|
Gag(18-26) | human epitope |
KIRLRPGGK
|
Gag(18-26) | human epitope |
KIRLRPGGK
|
Gag(18-26) | human epitope |
KIRLRPGGKK
|
Gag(18-27) | A*03 human epitope |
KIRLRPGGKK
|
Gag(18-27) | A*03, A*11, B*07, B*27 human epitope |
KIRLRPGGKK
|
Gag(18-27) | A*03:01 human epitope |
KIRLRPGGKK
|
Gag(18-27) | A11 human epitope |
KIRLRPGGKK
|
Gag(18-27) | A11 human epitope |
KIRLRPGGKK
|
Gag(18-27) | B*27 human epitope |
KIRLRPGGKK
|
Gag(18-27) | B*27 human epitope |
KIRLRPGGKK
|
Gag(18-27) | B27 human epitope |
KIRLRPGGKK
|
Gag(18-27) | B27 human epitope |
KIRLRPGGKK
|
Gag(18-27) | B27 human epitope |
KIRLRPGGKK
|
Gag(18-27) | B27 human epitope |
KIRLRPGGKK
|
Gag(18-27) | B27, B35 human epitope |
KIRLRPGGKK
|
Gag(18-27) | B*27:05 human epitope |
KIRLRPGGKKK
|
Gag(18-28) | human epitope |
KIRLRPGGrKr
|
Gag(18-28) | observed variant; susceptible form |
KIRLRPGGKKr
|
Gag(18-28) | observed variant; susceptible form |
KIRLReGGrKK
|
Gag(18-28) | observed variant |
KIRLRPaGKKK
|
Gag(18-28) | observed variant |
KIRLRPGGsKK
|
Gag(18-28) | observed variant |
KIRLRPGGKrK
|
Gag(18-28) | observed variant |
KIRLRPGGKKKYKL
|
Gag(18-31) | A3 human epitope |
KIRLRPGGKKKYKL
|
Gag(18-31) | B62 human epitope |
KIRLRPGGKKKYKLK
|
Gag(18-32) | B*57 human epitope |
KIRLRPGGKKKYKLK
|
Gag(18-32) | macaque epitope |
KIRLRPGGKKKYKLKHIVWASRELE
|
Gag(18-42) | A3 human epitope |
KIRLRPGGKKKYKLKHIVWASRELE
|
Gag(18-42) | A3 human epitope |
KIRLRPGGKKKYKLKHIVWASRELE
|
Gag(18-42) | B62 human epitope |
IRLRPGGKK
|
Gag(19-27) | A*03 human epitope |
IRLRPGGKK
|
Gag(19-27) | A*30 human epitope |
IRLRPGGKK
|
Gag(19-27) | A*68:02 human epitope |
IRLRPGGKK
|
Gag(19-27) | B*27 human epitope |
IRLRPGGKK
|
Gag(19-27) | B*27 human epitope |
IRLRPGGKK
|
Gag(19-27) | B*27 human epitope |
IRLRPGGKK
|
Gag(19-27) | B27 human epitope |
IRLRPGrKK
|
Gag(19-27) | observed variant |
IRLRPrrKK
|
Gag(19-27) | observed variant |
IRkRPGGKK
|
Gag(19-27) | observed variant |
IRLgPGGsK
|
Gag(19-27) | inferred escape |
IRLRPGGsK
|
Gag(19-27) | inferred escape |
IRLRPGGKK
|
Gag(19-27) | B27 human epitope |
IRLRPGGKK
|
Gag(19-27) | B27 human epitope |
IRLRPGGKK
|
Gag(19-27) | B27 human epitope |
IRLRPGGKK
|
Gag(19-27) | B27 human epitope |
IRLRPGGrK
|
Gag(19-27) | susceptible form |
IRLRPGGKK
|
Gag(19-27) | B27 human epitope |
IRLRPGGKK
|
Gag(19-27) | B27 human epitope |
IRLRPGGKK
|
Gag(19-27) | B27 scid-hu mouse epitope |
IRLRPGGKK
|
Gag(19-27) | B*27:02 human epitope |
IRLRPGGKK
|
Gag(19-27) | B*27:05 human epitope |
IRLRPGGKK
|
Gag(19-27) | B*27:05 human epitope |
IRLRPGGKK
|
Gag(19-27) | B*27:05 human epitope |
IRLRPGGKK
|
Gag(19-27) | B*27:05 human epitope |
IRLRPGGKK
|
Gag(19-27) | B*27:05 human epitope |
IRLRPGGKK
|
Gag(19-27) | B*27:05 human epitope |
IRLRPGGKK
|
Gag(19-27) | B*81 human epitope |
IRLRPGGKK
|
Gag(19-27) | B*82 human epitope |
IRLRPGGKK
|
Gag(19-27) | C*12 human epitope |
IRLRPGGKK
|
Gag(19-27) | human epitope |
IRLRPGGKK
|
Gag(19-27) | human epitope |
IRLRPGGKK
|
Gag(19-27) | human epitope |
IRLRPGGKK
|
Gag(19-27) | human epitope |
IRLRPGGKK
|
Gag(19-27) | human epitope |
IRLRPGGKK
|
Gag(19-27) | human epitope |
IRLRPGGKKK
|
Gag(19-28) | A11, A3, B62 human epitope |
IRLRPGGKKK
|
Gag(19-28) | human epitope |
IRLRPGGKKK
|
Gag(19-28) | human epitope |
IRLRPGGKKKY
|
Gag(19-29) | human epitope |
IRLRPGGrKrY
|
Gag(19-29) | non-susceptible form; observed variant |
IRLRPGGKKrY
|
Gag(19-29) | observed variant; susceptible form |
IRLReGGrKKY
|
Gag(19-29) | observed variant |
IRLRPGGKKKr
|
Gag(19-29) | observed variant |
IRLRPaGKKKY
|
Gag(19-29) | observed variant |
IRLRPGGsKKY
|
Gag(19-29) | observed variant |
IRLRPGGKrKY
|
Gag(19-29) | observed variant |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKc
|
Gag(20-28) | escape documented in this paper |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKq
|
Gag(20-28) | escape documented in this paper |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKq
|
Gag(20-28) | observed variant |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGrKK
|
Gag(20-28) | observed variant |
RLRPGGrKt
|
Gag(20-28) | escape documented in this paper |
RLRPGGKKq
|
Gag(20-28) | diminished HLA binding or increased off-rate; escape documented in this paper |
RLRPGGKKQ
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKk
|
Gag(20-28) | non-susceptible form |
RLRPGGKKr
|
Gag(20-28) | diminished response; escape documented in this paper; non-susceptible form |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKq
|
Gag(20-28) | diminished response; escape documented in this paper; non-susceptible form |
RLRPGGKKr
|
Gag(20-28) | diminished response; escape documented in this paper; non-susceptible form |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*03:01 human epitope |
{rWEKI}RLRPGGKKK
|
Gag(20-28) | inferred escape |
RLRPGGKKK
|
Gag(20-28) | A*03:01, A3, B42, B62 human epitope |
RLRPGGKKK
|
Gag(20-28) | A11 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKh
|
Gag(20-28) | subtype-specific susceptible form |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKh
|
Gag(20-28) | diminished response |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRQGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKt
|
Gag(20-28) | diminished response |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKqK
|
Gag(20-28) | escape documented in this paper |
RPRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKK
|
Gag(20-28) | A3 human epitope |
RLRPGGKKr
|
Gag(20-28) | susceptible form |
RLRPGGKKK
|
Gag(20-28) | A3, A30, A31, A68 epitope |
RLRPGGKKK
|
Gag(20-28) | A3, A30, B42, B62 human epitope |
RLRPGGKKq
|
Gag(20-28) | diminished response; susceptible form |
RLRPGGKKr
|
Gag(20-28) | susceptible form |
RLRPGGKKK
|
Gag(20-28) | A*30 human epitope |
RLRPGGKKK
|
Gag(20-28) | A*74 human epitope |
RLRPGGKKK
|
Gag(20-28) | B*07:02 human epitope |
RLRPGGKKK
|
Gag(20-28) | C*01 human epitope |
RLRPGGKKK
|
Gag(20-28) | human epitope |
RLRPGGKKR
|
Gag(20-28) | human epitope |
RLRPGGKKk
|
Gag(20-28) | susceptible form |
RLRPGGKKK
|
Gag(20-28) | human epitope |
RLRPGGKKK
|
Gag(20-28) | human epitope |
RLRPGGKKr
|
Gag(20-28) | susceptible form |
RLRPGGKKK
|
Gag(20-28) | human epitope |
RLRPGGKKK
|
Gag(20-28) | human epitope |
RLRPGGKKK
|
Gag(20-28) | human epitope |
RLRPGGKKK
|
Gag(20-28) | human epitope |
RLRPGGKKK
|
Gag(20-28) | human epitope |
RLRPGGKKK
|
Gag(20-28) | human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*03 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*03 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*03 human epitope |
RLFPGGKKKY
|
Gag(20-29) | A*03 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*03 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*03:01 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*03:01 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*03:01 human epitope |
RLRPGGKKqY
|
Gag(20-29) | observed variant |
RLRPGGKKKY
|
Gag(20-29) | A*03:01 human epitope |
RLRPGGKKqY
|
Gag(20-29) | HLA association |
RLRPGGKKKY
|
Gag(20-29) | A*03:01 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*03:01 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*03:01 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*03:01 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*03:01 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*03:01, A30 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A3 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A3 human epitope |
RLRPGGKKKK
|
Gag(20-29) | A3 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A3 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A3 human epitope |
RLRPGGKKhY
|
Gag(20-29) | susceptible form; subtype-specific susceptible form |
RLRPGGKKrY
|
Gag(20-29) | susceptible form; subtype-specific susceptible form |
RLRPGGKKqY
|
Gag(20-29) | susceptible form; subtype-specific susceptible form |
qLRPGGKKrY
|
Gag(20-29) | susceptible form; subtype-specific susceptible form |
RLRPGGKKKY
|
Gag(20-29) | A3, A30, B42, B62 human epitope |
RLRPGGKKHY
|
Gag(20-29) | A*30 human epitope |
RLRPGGKKqY
|
Gag(20-29) | observed variant |
RLRPGGKKrY
|
Gag(20-29) | observed variant |
RLRPGGKKcY
|
Gag(20-29) | observed variant |
kLRPGGKKqY
|
Gag(20-29) | observed variant |
RLRPGGKKKY
|
Gag(20-29) | A*30 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*30 human epitope |
RLRPGGKKqY
|
Gag(20-29) | diminished response |
RLRPGGKKrY
|
Gag(20-29) | diminished response |
RLRPGGKKHY
|
Gag(20-29) | A*30:01 human epitope |
RLRPGGKKKY
|
Gag(20-29) | A*30:01 human epitope |
RLRPGGKKqY
|
Gag(20-29) | HLA association |
RLRPGGKKKY
|
Gag(20-29) | B*15 human epitope |
RLRPGGKKKY
|
Gag(20-29) | B*15 human epitope |
RLRPGGKKKY
|
Gag(20-29) | B*15 human epitope |
RLRPGGKKKY
|
Gag(20-29) | B*15:01 human epitope |
RLRPGGKKKY
|
Gag(20-29) | B*15:40 human epitope |
RLRPGGKKKY
|
Gag(20-29) | B42 human epitope |
RLRPGGKKKY
|
Gag(20-29) | B42, B62 human epitope |
RLRPGGKKHY
|
Gag(20-29) | B*42:01 human epitope |
RLRPGGKKHY
|
Gag(20-29) | B*42:01 human epitope |
kLRPGGKKHY
|
Gag(20-29) | inferred escape |
kLRPGGKKrY
|
Gag(20-29) | inferred escape |
RLRPGGKKrY
|
Gag(20-29) | inferred escape |
RLRPGGKKqY
|
Gag(20-29) | inferred escape |
RLRPGGKKKY
|
Gag(20-29) | B*44 human epitope |
RLRPGGKKKY
|
Gag(20-29) | B62 human epitope |
RLRPGGrKKY
|
Gag(20-29) | susceptible form |
RLRPGGKKKY
|
Gag(20-29) | B62 human epitope |
RLRPGGKKKY
|
Gag(20-29) | B62 human epitope |
RLRPGGKKKY
|
Gag(20-29) | C*02 human epitope |
RLRPGGKKKY
|
Gag(20-29) | C*06 human epitope |
RLRPGGKKKY
|
Gag(20-29) | C*14 human epitope |
RLRPGGKKKY
|
Gag(20-29) | C*16 human epitope |
RLRPGGKKKY
|
Gag(20-29) | human epitope |
RLRPGGKKKY
|
Gag(20-29) | human epitope |
RLRPGGKKKY
|
Gag(20-29) | human epitope |
RLRPGGKKKY
|
Gag(20-29) | human epitope |
RLRPGGKKKYK
|
Gag(20-30) | human epitope |
RLRPGGKKrYK
|
Gag(20-30) | observed variant; susceptible form |
RLRPGGKKKYr
|
Gag(20-30) | observed variant; susceptible form |
RLRPGGrKrYK
|
Gag(20-30) | non-susceptible form; observed variant |
RLReGGrKKYK
|
Gag(20-30) | observed variant |
RLRPGGKKKrK
|
Gag(20-30) | observed variant |
RLRPGGKKKYq
|
Gag(20-30) | observed variant |
RLRPaGKKKYK
|
Gag(20-30) | observed variant |
RLRPGGsKKYK
|
Gag(20-30) | observed variant |
RLRPGGKrKYK
|
Gag(20-30) | observed variant |
RLRPGGKKKYK
|
Gag(20-30) | human epitope |
RLRPGGKKHYM
|
Gag(20-30) | human epitope |
RLRPGGKKRYRL
|
Gag(20-31) | human epitope |
RLRPGGKKkYRL
|
Gag(20-31) | subtype-specific susceptible form |
CLRPGGKKKYKLKHIV
|
Gag(20-35) | human epitope |
LRPGGKKKY
|
Gag(21-29) | C*06:02 human epitope |
LRPGGKKKY
|
Gag(21-29) | human epitope |
LRPGGKKRY
|
Gag(21-29) | human epitope |
LRPGrKKRY{KLKHlV}
|
Gag(21-29) | escape documented in this paper |
LRPGGKKKYKLKHIV
|
Gag(21-35) | A11, B7 human epitope |
LRPGGKKKYKLKHIV
|
Gag(21-35) | A3 human epitope |
LRPGGKKKYKLKHIV
|
Gag(21-35) | A3 human epitope |
LRPGGKKKYKLKHIV
|
Gag(21-35) | B*08 human epitope |
LRPGGKKqYKLKHIV
|
Gag(21-35) | susceptible form |
LRPGGKKKYKLKHIV
|
Gag(21-35) | B8 human epitope |
LRPGGKKKYKLKHIV
|
Gag(21-35) | B8 human epitope |
LRPGGKKKYKLKHIV
|
Gag(21-35) | human epitope |
LRPGGKKKYKLKHIV
|
Gag(21-35) | human epitope |
LRPGGKKrYKLKHIV
|
Gag(21-35) | susceptible form |
LRPGGKKKYrLKHlV
|
Gag(21-35) | susceptible form |
LRPGGKKKYrLKHIV
|
Gag(21-35) | susceptible form |
LRPGGKKKYRLKHLV
|
Gag(21-35) | human epitope |
LRPGGKKKYkLKHLV
|
Gag(21-35) | observed variant |
LRPGGKKKYKLKHIV
|
Gag(21-35) | human epitope |
LRPGGKKKYKLKHIV
|
Gag(21-35) | human epitope |
LRPGGKKKYRLKHLVWASRE
|
Gag(21-40) | Cw4 human epitope |
LRPGGKKKYkLKHiVWASRE
|
Gag(21-40) | subtype-specific non-susceptible form |
LRPGGKKKYKLKHIVWASRE
|
Gag(21-40) | human epitope |
LRPGGKKKYRLKHLVWASRE
|
Gag(21-40) | human epitope |
RPGGKKHY
|
Gag(22-29) | B42, B7 human epitope |
RPGGKKkY
|
Gag(22-29) | diminished response |
RPGGKKqY
|
Gag(22-29) | diminished response |
RPGGKKHYM
|
Gag(22-30) | B*07:02 human epitope |
RPGGKKkYk
|
Gag(22-30) | subtype-specific non-susceptible form |
RPGGKKHYM
|
Gag(22-30) | B*07:02 human epitope |
RPGGKKHYM
|
Gag(22-30) | B*07:02, B*42:01 human epitope |
RPGGKKqYM
|
Gag(22-30) | escape documented in this paper; replicative capacity reduced |
RPGGKKsYM
|
Gag(22-30) | escape documented in this paper; replicative capacity reduced |
RPGGKKHYr
|
Gag(22-30) | escape documented in this paper; replicative capacity reduced |
RPGGKKHYk
|
Gag(22-30) | escape documented in this paper; replicative capacity reduced |
RPGGKKHYM
|
Gag(22-30) | B*42:01 human epitope |
RPGGKKHYM
|
Gag(22-30) | B*42:01 human epitope |
{IsL}RPGGKKHYM
|
Gag(22-30) | escape documented in this paper; observed variant |
RPGGKKqYM
|
Gag(22-30) | diminished response; escape documented in this paper; observed variant |
RPGGKKsYM
|
Gag(22-30) | diminished response; escape documented in this paper; observed variant |
RPGGKKrYM
|
Gag(22-30) | diminished response; escape documented in this paper; observed variant |
RPGGKKHYk
|
Gag(22-30) | diminished response; escape documented in this paper; observed variant |
RPGGKKHYM
|
Gag(22-30) | B*42:01, B*42:02 human epitope |
RPGGKKrYM
|
Gag(22-30) | escape documented in this paper |
RPGGKKHYk
|
Gag(22-30) | observed variant |
RPGGKKHYr
|
Gag(22-30) | observed variant |
RPGGKKRYM
|
Gag(22-30) | human epitope |
RPGGKKKYML
|
Gag(22-31) | B*07:02, B*42:01 human epitope |
RPGGKKKYKL
|
Gag(22-31) | B*51:01 human epitope |
RPGGKKKYKL
|
Gag(22-31) | B*51:01 human epitope |
RPGGKKRYKL
|
Gag(22-31) | B7 human epitope |
RPGGKKKYKL
|
Gag(22-31) | Cw4 human epitope |
RPGGnKKYKL
|
Gag(22-31) | observed variant |
RPGGKKKYKL
|
Gag(22-31) | human epitope |
PGGKKRYRLKHL
|
Gag(23-34) | human epitope |
PGGKKkYRLKHL
|
Gag(23-34) | subtype-specific susceptible form |
GGKKKYKL
|
Gag(24-31) | B*08 human epitope |
GGKKKYKL
|
Gag(24-31) | B*08 human epitope |
GGrKKYKL
|
Gag(24-31) | reversion |
GGKKKYKL
|
Gag(24-31) | B*08 human epitope |
GGKKKYKL
|
Gag(24-31) | B*08 human epitope |
GGKKKYKL
|
Gag(24-31) | B*08:01 human epitope |
GGKKKYKL
|
Gag(24-31) | B*08:01 human epitope |
GGrKKYKL
|
Gag(24-31) | escape documented in this paper |
GGKKqYrL
|
Gag(24-31) | diminished HLA binding or increased off-rate; escape documented in this paper |
GGKKKYRL
|
Gag(24-31) | B*08:01 human epitope |
GGKKKYKL
|
Gag(24-31) | B8 human epitope |
GGKKKYKL
|
Gag(24-31) | B8 human epitope |
GGKKKYKf
|
Gag(24-31) | escape documented in this paper |
GGKKKYKL
|
Gag(24-31) | B8 human epitope |
GGKKKYKL
|
Gag(24-31) | B8 human epitope |
GGKKKYKL
|
Gag(24-31) | B8 human epitope |
GGKKKYRL
|
Gag(24-31) | B8 human epitope |
GGKKKYKL
|
Gag(24-31) | B8 human epitope |
GGKKKYrL
|
Gag(24-31) | subtype-specific non-susceptible form |
GGnKrYrL
|
Gag(24-31) | subtype-specific non-susceptible form |
GGKKKYqL
|
Gag(24-31) | subtype-specific non-susceptible form |
GGKKKYrm
|
Gag(24-31) | subtype-specific non-susceptible form |
GGsKKYKL
|
Gag(24-31) | subtype-specific non-susceptible form |
GGKKtYqL
|
Gag(24-31) | subtype-specific non-susceptible form |
GGKKKYKL
|
Gag(24-31) | B8 human epitope |
GGKKKYKm
|
Gag(24-31) | observed variant |
GGKKKYKL
|
Gag(24-31) | B8 human epitope |
GGKKKYKL
|
Gag(24-31) | B8 human epitope |
GGKKqYKL
|
Gag(24-31) | escape documented in this paper |
erKKqYKL
|
Gag(24-31) | observed variant |
GGKKKYKL
|
Gag(24-31) | B8 human epitope |
GGKKKYKL
|
Gag(24-31) | B8 human epitope |
GGKKKYKL
|
Gag(24-31) | C*01 human epitope |
GGKKKYKL
|
Gag(24-31) | human epitope |
GGKKKYKL
|
Gag(24-31) | human epitope |
GGKKKYKLK
|
Gag(24-32) | A*30 human epitope |
GGKKKYKLK
|
Gag(24-32) | B*08 human epitope |
GGKKKYKLK
|
Gag(24-32) | B*08 human epitope |
GGKKKYKLK
|
Gag(24-32) | B*08:01 human epitope |
GGKKKYKLK
|
Gag(24-32) | B*08:01 human epitope |
GGKKKYKLK
|
Gag(24-32) | B*08:01 human epitope |
GGKKKYKLK
|
Gag(24-32) | B8 human epitope |
GGKKKYKLK
|
Gag(24-32) | B8 human epitope |
GGKKKYKLK
|
Gag(24-32) | B8 epitope |
GGKKKYKLK
|
Gag(24-32) | B8 human epitope |
GGKKKYKLK
|
Gag(24-32) | B8 human epitope |
GGKKKYKLK
|
Gag(24-32) | B8 human epitope |
GGKKKYKLK
|
Gag(24-32) | B8 human epitope |
GGKKKYKLK
|
Gag(24-32) | B8 human epitope |
GGrKKYKLK
|
Gag(24-32) | escape documented in this paper; susceptible form |
GGKKKYKLK
|
Gag(24-32) | B8 human epitope |
GGKKKYKLK
|
Gag(24-32) | B8 human epitope |
GGKKKYKLK
|
Gag(24-32) | B8 human epitope |
GGKKKYKLK
|
Gag(24-32) | B8 human epitope |
GGKKKYKLK
|
Gag(24-32) | human epitope |
GGKKKYKLK
|
Gag(24-32) | human epitope |
GGKKKYQLK
|
Gag(24-32) | human epitope |
GGKKKYKLKHIV
|
Gag(24-35) | B8 human epitope |
GGKKKYKLKHIi
|
Gag(24-35) | susceptible form |
GrKKKYKLKHIV
|
Gag(24-35) | escape documented in this paper |
GrKKKYKfKHIV
|
Gag(24-35) | escape documented in this paper |
rGKKrYKLKHIV
|
Gag(24-35) | observed variant |
GGKKqYrLKHIV
|
Gag(24-35) | observed variant |
GGKKKYqLKHIV
|
Gag(24-35) | observed variant |
GGKKKYaLKHli
|
Gag(24-35) | observed variant |
GGKKKYKLKHIV
|
Gag(24-35) | B8 human epitope |
GGKKKYKLKHIVWASR
|
Gag(24-39) | human epitope |
GKKPYMLKHL
|
Gag(25-34) | human epitope |
GKKsYMLKHL
|
Gag(25-34) | diminished response; escape documented in this paper |
GKKPYrLKHL
|
Gag(25-34) | diminished response; escape documented in this paper |
GKKKYKLKHIVWASR
|
Gag(25-39) | A24, B7 human epitope |
GKKHYMIKHLVWASR
|
Gag(25-39) | human epitope |
GKKHYMlKHLVWASR
|
Gag(25-39) | susceptible form |
GrKkYrlKHiVWASR
|
Gag(25-39) | susceptible form |
-KKkYrmKHLVWASRE
|
Gag(25-39) | susceptible form |
GKKkYrIKHLV-ASRE
|
Gag(25-39) | susceptible form |
GKKKYKLKHIVWASR
|
Gag(25-39) | human epitope |
GKKHYMLKHLVWASR
|
Gag(25-39) | human epitope |
GKKHYMLKHLVWASR
|
Gag(25-39) | human epitope |
GrKkYrLKHiVWASR
|
Gag(25-39) | susceptible form |
GKKkYrLKHLV-ASRE
|
Gag(25-39) | susceptible form |
GKKHYMiKHLVWASR
|
Gag(25-39) | susceptible form |
-KKkYrmKHLVWASRE
|
Gag(25-39) | susceptible form |
GRKKYRLKHIVWASR
|
Gag(25-39) | human epitope |
GkKhYmLKHlVWASR
|
Gag(25-39) | susceptible form |
GkKhYmiKHlVWASR
|
Gag(25-39) | susceptible form |
GkKKYRLKHlV-ASRE
|
Gag(25-39) | susceptible form |
-kKKYRmKHlVWASRE
|
Gag(25-39) | susceptible form |
GKKKYRLKHLVASRE
|
Gag(25-40) | human epitope |
GKKhYmLKHLVWASR
|
Gag(25-40) | susceptible form |
GrKKYRLKHiVWASR
|
Gag(25-40) | susceptible form |
GKKhYmiKHLVWASR
|
Gag(25-40) | susceptible form |
-KKKYRmKHLVWASRE
|
Gag(25-40) | susceptible form |
GKKHYMLKHLVWASREL
|
Gag(25-41) | C*03 human epitope |
GKKQYKLKHIVWASRELE
|
Gag(25-42) | human epitope |
KKKYRMKHLVWASRE
|
Gag(26-40) | human epitope |
GrKKYRlKHiVWASR
|
Gag(26-40) | susceptible form |
GKKhYmlKHLVWASR
|
Gag(26-40) | susceptible form |
GKKhYmiKHLVWASR
|
Gag(26-40) | susceptible form |
GKKKYRlKHLV-ASRE
|
Gag(26-40) | susceptible form |
KKHYMLKHIVWASRE
|
Gag(26-40) | human epitope |
KKHYMLKHlVWASRE
|
Gag(26-40) | subtype-specific susceptible form |
{g}KKkYkLKHlVWASR
|
Gag(26-40) | subtype-specific non-susceptible form |
KKkYrLKHlVWASRE
|
Gag(26-40) | subtype-specific non-susceptible form |
KKkYrLKHlVWASRE
|
Gag(26-40) | subtype-specific non-susceptible form |